Drug profile · INN
insulin glargine recombinant
TOUJEO SOLOSTAR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
insulin glargine recombinant (TOUJEO SOLOSTAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN insulin glargine recombinant
Brand TOUJEO SOLOSTAR
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is insulin glargine recombinant?
insulin glargine recombinant (TOUJEO SOLOSTAR) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for insulin glargine recombinant?
TOUJEO SOLOSTAR is a marketed brand name for insulin glargine recombinant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin glargine recombinant?
insulin glargine recombinant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.